INM Company Profile and Key Details

Q: Who are the executives of INM?

Dr. Sazzad Hossain M.Sc., Ph.D.Co-FounderMr. Michael Woudenberg P.Eng.Chief Operating OfficerDr. Shane A. Johnson Ph.D.Senior Vice President & GM of BayMedicaMs. Sarah Li C.P.A., CGAVice President of Accounting & ControllerMs. Brenda Edwards C.M.A., C.P.A.Chief Accounting OfficerDr. Ado MuhammadSenior Consultant of Medical AffairsMr. Jonathan R. TeggeInterim Chief Financial OfficerMs. Sarah LiVice President of Accounting, Controller & Principal Accounting OfficerDr. Eric Chih-Hsien HsuSenior Vice President of Preclinical R&DMs. Sarah Li CPA, CGAVice President of Accounting & ControllerColin ClancySenior Director of Investor RelationsMs. Alexandra Diane-Janet Mancini M.Sc.Senior Vice President of Clinical & Regulatory AffairsMr. Jerry P. GriffinVice President of Sales & MarketingMr. Eric A. Adams B.S. Chem., M.I.B.Pres, Chief Executive Officer & Director

NASDAQ : INM

InMed Pharmaceuticals

$1.40

0.02+1.45%

At Close 4:00 PM

63.64

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

InMed Pharmaceuticals Inc. (INM) stock surged +1.45%, trading at $1.40 on NASDAQ, up from the previous close of $1.38. The stock opened at $1.38, fluctuating between $1.38 and $1.42 in the recent session.

Stock Snapshot

1.38

Prev. Close

2.53M

Market Cap

1.38

Day Low

-0.26

P/E Ratio

-5.44

EPS (TTM)

-0.82

Cash Flow per Share

1.38

Open

1.81M

Number of Shares

1.42

Day High

98.44%

Free Float in %

1.6

Book Value

38.96K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 24, 2026	1.39	1.42	1.37	1.40	38.96K
Sep 23, 2026	1.39	1.41	1.38	1.38	49.15K
Sep 21, 2026	1.38	1.46	1.37	1.38	120K
Sep 18, 2026	1.39	1.40	1.36	1.36	10.33K
Sep 17, 2026	1.49	1.51	1.32	1.39	317.24K
Sep 16, 2026	1.26	1.31	1.26	1.28	19.75K
Sep 15, 2026	1.27	1.31	1.25	1.28	79.06K
Sep 14, 2026	1.29	1.32	1.27	1.30	58.46K
Sep 11, 2026	1.33	1.35	1.29	1.29	28.14K
Sep 10, 2026	1.31	1.34	1.29	1.31	20.5K
Sep 09, 2026	1.31	1.33	1.28	1.31	52.78K
Sep 08, 2026	1.36	1.39	1.31	1.33	62.98K
Sep 04, 2026	1.34	1.40	1.33	1.38	7.49K
Sep 03, 2026	1.34	1.39	1.32	1.33	45.54K
Sep 02, 2026	1.36	1.40	1.33	1.35	19.89K
Sep 01, 2026	1.35	1.35	1.30	1.32	96.74K
Aug 31, 2026	1.36	1.42	1.35	1.35	90.05K
Aug 28, 2026	1.43	1.43	1.38	1.38	111.85K
Aug 27, 2026	1.42	1.45	1.41	1.43	29.78K
Aug 26, 2026	1.48	1.48	1.36	1.43	60.91K

Contact Details

Vancouver, BC V6C 3E8

Canada

https://www.inmedpharma.com 604 669 7207

About Company

InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary product, INM-755, is a cannabinol-infused topical cream that is currently progressing through its second Phase I clinical trial for the management of epidermolysis bullosa. Beyond this lead candidate, the company is also developing INM-088, which is undergoing preclinical studies for glaucoma treatment, and INM-405, intended for pain relief. Its broader development pipeline encompasses cannabinoid-based interventions for a variety of medical conditions, with a particular focus on dermatological and ocular disorders. Furthermore, InMed is involved in critical IND-enabling pharmacology and preclinical toxicology research. It is also pioneering IntegraSyn, an innovative integrated biosynthesis approach designed to produce pharmaceutical-grade cannabinoids efficiently. The company maintains a research partnership with BayMedica Inc. to collaborate on the formulation and assessment of novel cannabinoid therapeutics. Established in 1981, the company is headquartered in Vancouver, Canada. It operated under the name Cannabis Technologies Inc. before officially rebranding as InMed Pharmaceuticals Inc. in October 2014.

Stock Peers

ITCI

Intra-Cellular Therapies, Inc.$131.87 LNTH

-0.25-0.25%

Lantheus Holdings, Inc.$99.72 ANIP

-0.39-0.52%

ANI Pharmaceuticals, Inc.$74.04 ETON

3.88+6.98%

Eton Pharmaceuticals, Inc.$59.49 SUPN

-0.1-0.23%

Supernus Pharmaceuticals, Inc.$43.29 ALKS

-1.34-3.18%

Alkermes plc$40.79 INDV

0.09+0.25%

Indivior Pharmaceuticals Inc$36.00 PAHC

-0.17-0.50%

Phibro Animal Health Corporation$33.93 HROW

-0.5-1.49%

Harrow Health, Inc.$33.10 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98

Frequently Asked Questions

What is the current InMed Pharmaceuticals Inc. (INM) stock price?

InMed Pharmaceuticals Inc. (NASDAQ: INM) stock price is $1.40 in the last trading session. During the trading session, INM stock reached the peak price of $1.42 while $1.38 was the lowest point it dropped to. The percentage change in INM stock occurred in the recent session was 1.45% while the dollar amount for the price change in INM stock was $0.02.

INM's industry and sector of operation?

The NASDAQ listed INM is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. InMed Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INM?

Dr. Sazzad Hossain M.Sc., Ph.D.
Co-Founder
Mr. Michael Woudenberg P.Eng.
Chief Operating Officer
Dr. Shane A. Johnson Ph.D.
Senior Vice President & GM of BayMedica
Ms. Sarah Li C.P.A., CGA
Vice President of Accounting & Controller
Ms. Brenda Edwards C.M.A., C.P.A.
Chief Accounting Officer
Dr. Ado Muhammad
Senior Consultant of Medical Affairs
Mr. Jonathan R. Tegge
Interim Chief Financial Officer
Ms. Sarah Li
Vice President of Accounting, Controller & Principal Accounting Officer
Dr. Eric Chih-Hsien Hsu
Senior Vice President of Preclinical R&D
Ms. Sarah Li CPA, CGA
Vice President of Accounting & Controller
Colin Clancy
Senior Director of Investor Relations
Ms. Alexandra Diane-Janet Mancini M.Sc.
Senior Vice President of Clinical & Regulatory Affairs
Mr. Jerry P. Griffin
Vice President of Sales & Marketing
Mr. Eric A. Adams B.S. Chem., M.I.B.
Pres, Chief Executive Officer & Director

How INM did perform over past 52-week?

INM's closing price is 143.48% higher than its 52-week low of $0.58 where as its distance from 52-week high of $2.50 is -44%.

How many employees does INM have?

Number of INM employees currently stands at 6.

Link for INM official website?

Official Website of INM is: https://www.inmedpharma.com

How do I contact INM?

INM could be contacted at phone 604 669 7207 and can also be accessed through its website. INM operates from 815 West Hastings Street, Vancouver, BC V6C 3E8, Canada.

How many shares of INM are traded daily?

INM stock volume for the day was 38.96K shares. The average number of INM shares traded daily for last 3 months was 928.57K.

What is the market cap of INM currently?

The market value of INM currently stands at $2.53M with its latest stock price at $1.40 and 1.81M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	6
Beta	0.98
Sales or Revenue	$3.18B
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Employees	6
Beta	0.98
Sales or Revenue	$3.18B
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

INM Company Profile and Key Details

InMed Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways